Gerresheimer AG (ETR:GXI) has received an average recommendation of “Hold” from the ten analysts that are presently covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, four have issued a hold recommendation and four have issued a buy recommendation on the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is €70.97 ($82.52).

A number of research analysts recently issued reports on the company. Credit Suisse Group set a €87.00 ($101.16) target price on Gerresheimer and gave the company a “buy” rating in a report on Tuesday, October 15th. Hauck & Aufhaeuser set a €50.00 ($58.14) target price on Gerresheimer and gave the company a “sell” rating in a report on Wednesday, November 20th. Berenberg Bank set a €81.00 ($94.19) target price on Gerresheimer and gave the company a “buy” rating in a report on Wednesday, November 20th. HSBC set a €85.00 ($98.84) price target on Gerresheimer and gave the stock a “buy” rating in a report on Monday, October 14th. Finally, Goldman Sachs Group set a €65.00 ($75.58) price target on Gerresheimer and gave the stock a “neutral” rating in a report on Tuesday, November 19th.

ETR:GXI opened at €67.80 ($78.84) on Friday. The firm has a market cap of $2.11 billion and a PE ratio of 10.28. The stock has a fifty day moving average price of €69.49 and a 200 day moving average price of €67.89. Gerresheimer has a 12-month low of €51.10 ($59.42) and a 12-month high of €74.80 ($86.98). The company has a current ratio of 0.81, a quick ratio of 0.54 and a debt-to-equity ratio of 65.99.

About Gerresheimer

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through three divisions; Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Featured Story: What are the qualifications of a portfolio manager?

Analyst Recommendations for Gerresheimer (ETR:GXI)






Source link